30 Participants Needed

Sleep Regularity for Cardiovascular Health

(DISCO Trial)

BM
AW
Overseen ByAndrew W McHill, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Oregon Health and Science University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if maintaining a regular sleep schedule can improve heart and metabolic health. Participants will either follow a set sleep routine (Sleep Regularity Group) or maintain their usual sleep habits for 12 weeks. The trial seeks generally healthy adults without heart issues, diabetes, or sleep disorders, and who have not recently worked night shifts. Participants must also be non-smokers and free from alcohol or drug dependency. As an unphased trial, this study provides participants the chance to contribute to valuable research that could enhance understanding of sleep's impact on health.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, since the study involves ostensibly healthy individuals without certain health conditions, it's possible that some medications might not be allowed. It's best to discuss your specific medications with the study team.

What prior data suggests that this protocol is safe for cardiovascular health?

Research has shown that a regular sleep schedule is linked to better heart health. Studies have found that people with irregular sleep patterns face a higher risk of heart problems and other health issues. Inconsistent sleep is associated with a greater risk of heart disease and even early death.

The treatment in this clinical trial aims to improve sleep regularity. Participants will go to bed at the same time each night, within about 30 minutes of their chosen bedtime. This trial involves no drugs or invasive procedures, only a change in sleep habits.

Since this trial focuses on adjusting sleep habits rather than taking medication, it is generally considered safe. No reports of serious side effects have emerged from simply changing sleep schedules. The goal is to determine if making sleep more regular can improve heart and metabolic health.

In summary, regularizing sleep schedules is not only safe but could also benefit heart health.12345

Why are researchers excited about this trial?

Researchers are excited about the Sleep Regularity intervention for improving cardiovascular health because it focuses on enhancing the consistency of sleep patterns rather than introducing new medications or invasive procedures. Unlike traditional treatments that might involve drugs for managing cardiovascular risk factors, this method encourages individuals to maintain a consistent sleep schedule, which could offer a natural and sustainable way to improve heart health. By targeting sleep regularity, this approach aims to harness the body's natural rhythms to potentially reduce cardiovascular issues, offering a promising, low-risk alternative to current treatment options.

What evidence suggests that improving sleep regularity might be effective for cardiovascular health?

This trial will compare the effects of sleep regularity on cardiovascular health. Research has shown that a regular sleep schedule can greatly improve heart health. Participants in the Sleep Regularity Group will undergo a 12-week intervention to enhance sleep regularity. Studies have found that irregular sleep patterns are linked to a higher risk of heart problems and even a shorter lifespan. By maintaining a consistent sleep routine, participants can lower the chances of heart-related issues, such as conditions that increase heart disease risk and early artery damage. Keeping a regular sleep schedule may also aid in recovering from heart conditions. Overall, maintaining a steady sleep routine supports better heart and overall health.12678

Who Is on the Research Team?

AW

Andrew W McHill, PhD

Principal Investigator

Oregon Health and Science University

Are You a Good Fit for This Trial?

This trial is for healthy men and women aged 18-40 who are interested in how sleep patterns affect heart health. Participants should have a regular daily routine but may have varying sleep schedules. The study excludes those with known cardiovascular or metabolic disorders, shift workers, pregnant individuals, and anyone on medication affecting sleep or circadian rhythms.

Inclusion Criteria

I am generally healthy.

Exclusion Criteria

I have pre-diabetes or diabetes.
I have a gastrointestinal condition.
Chronobiologic and sleep disorders
See 15 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Outpatient Biobehavioral Weeks

Actigraphy data collected across 2-weeks to assess habitual sleep patterns and calculate a sleep regularity index (SRI)

2 weeks
Continuous monitoring with actigraphy device

Biobehavioral Laboratory Visit

Participants visit the laboratory for two in-laboratory visits in dim-light settings, involving an evening stay to measure circadian markers, body composition, and vascular function

1 week
2 visits (in-person)

Ambulatory Monitoring

Biobehavioral data collection at Weeks 1-2, Weeks 6-7, and Weeks 11-12 for intervention group; Weeks 11-12 for control group. Includes actigraphy, sleep logs, ambulatory blood pressure, and glucose monitoring

12 weeks
Continuous monitoring with actigraphy and glucose monitor

Follow-up

Participants are monitored for changes in cardiovascular and metabolic markers post-intervention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Sleep Regularity Group
Trial Overview The study is examining the impact of consistent sleep times on heart and blood vessel health over a 12-week period. It involves tracking participants' normal life routines as well as specific assessments conducted in a lab setting to measure changes in their cardiometabolic health.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep Regularity GroupExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Oregon Health and Science University

Lead Sponsor

Trials
1,024
Recruited
7,420,000+

Medical Research Foundation, Oregon

Collaborator

Trials
14
Recruited
1,100+

Published Research Related to This Trial

In a study of 1,978 older adults, greater sleep irregularity, measured by the Sleep Regularity Index (SRI), was linked to increased risks of cardiovascular disease and various metabolic issues like obesity and diabetes, independent of total sleep duration.
The findings suggest that sleep irregularity could be a significant factor in identifying and preventing cardiometabolic diseases, highlighting the need for further research into the mechanisms behind this relationship and potential sleep interventions.
Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.Lunsford-Avery, JR., Engelhard, MM., Navar, AM., et al.[2022]
In a study of 36,480 Brazilian adults, those without sleep disturbances had significantly better cardiovascular health, as indicated by higher Life's Simple 7 (LS7) scores, compared to those experiencing sleep issues.
The severity of sleep disturbances was directly linked to lower cardiovascular health scores, with individuals reporting disturbances almost every day having the lowest scores, suggesting that improving sleep quality could be important for enhancing cardiovascular health.
Association of self-reported sleep disturbances with ideal cardiovascular health in Brazilian adults: A cross-sectional population-based study.Velasquez-Melendez, G., Andrade, FCD., Moreira, AD., et al.[2022]
Sleep impairment is not only a consequence of cardiovascular diseases but can also increase the risk of conditions like hypertension and stroke, highlighting the importance of monitoring heart rate abnormalities during sleep for early detection of cardiovascular issues.
Melatonin may play a crucial role in regulating cardiovascular function and sleep patterns, as disruptions in the circadian cycle and chronic sleep deficits are linked to increased sympathetic nervous system activity and a higher risk of obesity and cardiovascular diseases.
Sleep and vascular disorders.Plante, GE.[2015]

Citations

The Emerging Importance of Sleep Regularity on ...Low sleep regularity was consistently associated with higher cardiovascular risk and elevated risk of all-cause mortality. Results on cognitive ...
Sleep Patterns and Traditional Cardiovascular Health MetricsEnhanced CVH significantly reduced CVD risk, even in individuals with a poor sleep pattern. These results emphasize the importance of ...
A contemporary review of sleep and cardiovascular healthSleep regularity has emerged as a strong and independent risk factor for CVD-related mortality, cardiometabolic syndrome, and subclinical atherosclerosis. Less ...
Regular sleep schedule may improve recovery from heart ...Regular sleep schedule may improve recovery from heart failure, study finds OHSU review suggests a consistent sleep schedule is especially ...
The impact of sleep health on cardiovascular and all-cause ...Sleep patterns are important predictors of long-term health outcomes. We investigated the associations of sleep duration, sleep regularity, ...
Device-Measured Sleep Characteristics, Daily Step Count, ...Sleep regularity and steps, and sleep duration and steps showed clear and graded associations with overall cardiometabolic health (Figure 1). We ...
The importance of sleep regularity: a consensus statement ...SRI independent of sleep duration. Greater sleep irregularity correlated with 10-y risk of cardiovascular disease, greater obesity, hypertension ...
Sleep regularity is a stronger predictor of mortality risk than ...Studies with longitudinal measures of sleep regularity have found associations between irregular sleep and adverse cardiometabolic outcomes [12, 14–17], ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security